Lenalidomide Amarox (Lenalidomide)

Lenalidomide binds to cereblon, a component of the CRL4CRBN E3 ubiquitin ligase complex. This binding changes the complex’s substrate specificity, leading to the ubiquitination and degradation of transcription factors Ikaros and Aiolos. The resulting anti‑angiogenic, immunomodulatory, and anti‑proliferative actions suppress malignant cell growth and restore normal immune function.

The dosage of Lenalidomide Amarox is individualized and determined by the prescribing physician based on the specific indication, disease severity, renal function, and patient tolerance. Healthcare professionals follow approved prescribing information and adjust the regimen as needed during treatment.

Lenalidomide Amarox is classified as Pregnancy Category X because it is teratogenic and can cause fetal harm. It is contraindicated in pregnant women and should not be used by women who are or may become pregnant without effective contraception. Breastfeeding is also not recommended, as the drug may be excreted in milk.

To order Lenalidomide Amarox, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details (including any required temperature control), and assistance with import documentation.

The primary alternative to Lenalidomide is thalidomide, another immunomodulatory agent. Lenalidomide generally offers a more favorable safety profile, with lower rates of peripheral neuropathy and better efficacy in certain cytogenetic subtypes of myelodysplastic syndromes. However, both drugs share risks such as thrombosis and teratogenicity, so selection depends on individual patient factors and physician judgment.

Lenalidomide Amarox tablets should be stored at temperatures below 25 °C. Keep them in the original blister pack or container, protect from moisture and direct sunlight, and ensure the packaging remains tightly closed until use. Do not store in a refrigerator or freezer.

Lenalidomide Amarox is administered orally as a tablet. It can be taken with or without food, but patients should follow the prescribing physician’s instructions regarding timing and any required dose adjustments. Swallow the tablet whole with water and avoid crushing or chewing unless specifically directed.

Serious risks include venous thromboembolism, severe neutropenia that can lead to life‑threatening infections, secondary primary malignancies, and significant hepatic toxicity. Patients should be monitored regularly for signs of infection, blood clot formation, liver function abnormalities, and any unexpected skin reactions. Prompt medical attention is required if any of these events occur.

Lenalidomide Amarox should not be used by pregnant women, individuals with known hypersensitivity to lenalidomide or its excipients, and patients with severe renal impairment unless dose adjustments are made under specialist guidance. Caution is also advised for patients with a history of thromboembolic events, severe hepatic disease, or uncontrolled infections.